BIOA

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total common shares outstanding 35.85 M35.85 M35.85 M35.86 M44.38 M — Enterprise value -138.28 M-115.63 M-66.67 M-619.38 K400.9 M 217.98 M Price to earnings ratio -0.87—0.510.41-5.91 — Price to sales ratio -203.63—38.3335.6352.85 — Price to cash flow ratio -1.21—-0.71-2.99-5.82 — Price to book ratio 0.19—0.030.111.75 — Enterprise value to EBITDA ratio 1.84—0.760.02-4.26 — Return on assets % -0.06-0.04-0.07-0.07-0.09 -0.26 Return on equity % -0.07-0.04-0.07-0.07-0.1 -0.28 Return on invested capital % -565.89———-451.41 — Gross margin % —100100100100 400 Operating margin % —-1 133.43-1 026.99-1 126.58-923.42 -4 210.42 EBITDA margin % —-1 130.88-1 024.59-1 124.2-921.18 -4 200.84 Net margin % —-890.97-893.99-982.04-842.85 -3 609.85 Quick ratio ————— — Current ratio 12.8613.6813.2111.8714.24 53.01 Inventory turnover ————— — Asset turnover 000.010.010.01 0.03 Debt to assets ratio 0.020.020.020.010.01 0.06 Debt to equity ratio 0.030.020.020.010.01 0.07 Long term debt to total assets ratio 0.010000 0 Long term debt to total equity ratio 0.010000 0 Operating cash flow per share -0.48-0.48-0.56-0.45-0.79 -2.28 EBIT per share -2.36-0.46-0.69-0.65-0.79 -2.59 EBITDA per share -2.36-0.46-0.69-0.64-0.79 -2.58 Total debt per share 0.790.20.160.120.07 0.54 Cash per share 33.038.948.297.977.82 33.03 Net current asset value per share 33.299.068.428.117.98 33.57 Tangible book value per share 30.128.748.227.747.57 32.27 Working capital per share 30.78.47.787.437.42 31.03 Book value per share 30.128.748.227.747.57 32.27